These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 16253089)
21. In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes. Vandooren B; Melis L; Veys EM; Tak PP; Baeten D Arthritis Rheum; 2009 Apr; 60(4):1020-5. PubMed ID: 19333923 [TBL] [Abstract][Full Text] [Related]
23. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Dai SM; Nishioka K; Yudoh K Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886 [TBL] [Abstract][Full Text] [Related]
24. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha). Woo JT; Nakagawa H; Krecic AM; Nagai K; Hamilton AD; Sebti SM; Stern PH Biochem Pharmacol; 2005 Jan; 69(1):87-95. PubMed ID: 15588717 [TBL] [Abstract][Full Text] [Related]
26. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha. Ma T; Miyanishi K; Suen A; Epstein NJ; Tomita T; Smith RL; Goodman SB Cytokine; 2004 May; 26(3):138-44. PubMed ID: 15135808 [TBL] [Abstract][Full Text] [Related]
27. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1. Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321 [TBL] [Abstract][Full Text] [Related]
28. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia. Olivier BJ; Schoenmaker T; Mebius RE; Everts V; Mulder CJ; van Nieuwkerk KM; de Vries TJ; van der Merwe SW Hepatology; 2008 Jan; 47(1):259-67. PubMed ID: 18022900 [TBL] [Abstract][Full Text] [Related]
29. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [TBL] [Abstract][Full Text] [Related]
30. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis. Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732 [TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1). Kwak HB; Jin HM; Ha H; Kang MJ; Lee SB; Kim HH; Lee ZH Biochem Biophys Res Commun; 2005 May; 330(4):1080-6. PubMed ID: 15823554 [TBL] [Abstract][Full Text] [Related]
34. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation. Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498 [TBL] [Abstract][Full Text] [Related]
35. T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction. Colucci S; Brunetti G; Rizzi R; Zonno A; Mori G; Colaianni G; Del Prete D; Faccio R; Liso A; Capalbo S; Liso V; Zallone A; Grano M Blood; 2004 Dec; 104(12):3722-30. PubMed ID: 15308561 [TBL] [Abstract][Full Text] [Related]
36. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis. Merle B; Itzstein C; Delmas PD; Chenu C J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357 [TBL] [Abstract][Full Text] [Related]
37. Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis. Mori G; Cantatore FP; Brunetti G; Oranger A; Colaianni G; Quarta L; Corrado A; Colucci S; Grano M Ann N Y Acad Sci; 2007 Nov; 1117():159-64. PubMed ID: 17646267 [TBL] [Abstract][Full Text] [Related]
38. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627 [TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722 [TBL] [Abstract][Full Text] [Related]
40. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Yamaguchi M; Uchiyama S Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]